Latest

Cedars-Sinai Event Explores Ethics of Longevity Science | Newswise — Photo by Elvin Muradzade on Pexels

longevity science

The Complete Guide to How Private Philanthropy Shapes Ethical Priorities in Longevity Science: Insights from the Cedars‑Sinai Event

78% of private philanthropic grants for longevity research come from families tied to pharmaceutical wealth, shaping which ethical questions receive funding. In the weeks leading up to the Cedars-Sinai summit, I followed the discourse closely, noting how donors’ agendas began to echo in the panel’s agenda. Medical Disclaimer: This

Cedars-Sinai Event Explores Ethics of Longevity Science | Newswise — Photo by mori dad on Pexels

longevity science

Build a Bottom‑Up Budget: Cedars‑Sinai’s Ethics Panel Breaks Down Longevity Science Costs and Gene Therapy Pricing

Only 53% of FDA-approved gene therapies are priced below the average cost of anti-cancer treatments, showing the market often overcharges for longevity interventions. I unpack how Cedars-Sinai’s ethics panel separates hype from real value, revealing hidden costs and equity challenges. Medical Disclaimer: This article is for informational purposes only